GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Myasthenia Gravis
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
China Multiple MyelomaChina NMPA
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
Trials & Approvals Alzheimer's Disease
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
Trials & Approvals Graft Versus Host Disease
BMS’ Drug Wins First-In-Class Approval for Prevention of Acute Graft-Versus-Host Disease
2021-12-17
Regulatory T-cell Therapy
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Trials & Approvals Cancer
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Trials & Approvals Prostate Cancer
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
Trials & Approvals Acute Myeloid Leukemia
FDA Places Clinical Hold on Kura Oncology’s Acute Myeloid Leukemia Therapeutic
2021-11-25
Trials & Approvals Organ Transplant
Takeda’s Livtencity Bags FDA Approval for the Treatment of Post-Transplant Infection
2021-11-24
Trials & Approvals Cancer
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Trials & Approvals Gene Therapy
FDA Grants Priority Review for bluebird bio’s β-Thalassemia Gene Therapy
2021-11-23
Trials & Approvals Dwarfism
BioMarin’s Dwarfism Drug Garners FDA Nod Amidst Concerns Over Threat to Dwarf Pride
2021-11-21
Trials & Approvals Keytruda
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Trials & Approvals Alzheimer's Disease
Brigham and Women’s Hospital Initiates First Clinical Trial of Nasal Vaccine for Alzheimer’s Disease
2021-11-18
Trials & Approvals Type 1 Diabetes
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
1 … 25 26 27 28 29 … 53
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top